Vermont Hub and Spoke Model Treatment Need Questionnaire

Similar documents
The Care Alliance for Opioid Dependence

Management Options for Opioid Dependence:

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

TELEPHONE SCREENING DEMOGRAPHIC INFO

8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door

Medication-Assisted Treatment. What Is It and Why Do We Use It?

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

Opioid Withdrawal, Opioid Substitution, and HIV Infection

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

The science of the mind: investigating mental health Treating addiction

OPIOID USE DISORDER CENTERS OF EXCELLENCE APPLICATION GENERAL INFORMATION

Closing the Loop in Treating Opioid Addiction:

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Status of Opioid Treatment Efforts

Caring for ME Lunch & Learn Webinar

Your Child s Treatment Roadmap

Treatment Approaches for Drug Addiction

Hospitals Role in Addressing the Opioid Crisis

What I Want From Treatment User Information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

The CARA & Buprenorphine Prescribing for APNs & PAs

Opiate Use Disorder and Opiate Overdose

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Opioid Treatment Program Reimbursement Re-bundling Proposal

Patient and Family Agreement on Opioids

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Management of Opioid Use Disorder in Primary Care

Understanding Medication in Addiction Treatment for Drug Court Participants

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Project Connections Buprenorphine Program

THA Medication Safety Summit. Wesley Geminn, PharmD, BCPP

What To Expect From Counseling

DPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Opioid Withdrawal, Opioid Substitution Treatment, and HIV Infection

VIRGINIA MEDICAID PERSPECTIVE ON BEST PRACTICES IN THE TREATMENT OF OPIOID USE DISORDER

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

Opioids Research to Practice

Methadone Treatment. in federal prison

OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

Improving Outcomes in Methadone Treatment

California Hub and Spoke System Evaluation

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

THE UNSTABLE BUPRENORPHINE- NALOXONE PATIENT

Opioids Research to Practice

Medicaid and the Opioid Crisis

GOALS AND OBJECTIVES

Treatment of Youth Opioid Addiction: Approaches to a Modern Epidemic. What should we do with this case? Heroin Addiction History

Brief History of Methadone Maintenance Treatment

Methadone Treatment. in federal prison

Public Policy Statement on the Regulation of Office-Based Opioid Treatment

1) To understand the scope of the opioid epidemic with relation to Emergency Departments 2) To gain insight into some emerging Emergency Medicine

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Rationale & Strategy For Integrating Buprenorphine Treatment Into Community Health Centers

RECOMMENDATIONS FOR HEALTH CARE PROVIDERS

Driving Under the Influence (DUI) Medication Assisted Treatment (MAT) Integration/Outreach Pilot Project. Stakeholder Informing Webinar February 2019

MAGELLAN VA MEDICAID/DMAS RATES

MEDICATION ASSISTED TREATMENT

Medication Assisted Treatment

Vivitrol Drug Court and Medication Assisted Treatment

NURSING INTAKE. Provider Name: Provider Signature: Nursing Summary. Are you pregnant at this time?

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

Substance use and misuse

Opioid Withdrawal, Opioid Substitution, and HIV Infection

Understanding and Combating the Heroin Epidemic

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

Clinical Guidelines for the Pharmacologic Treatment of Opioid Use Disorder

Addiction and Recovery Treatment Services (ARTS) Reimbursement Structure

GoToWebinar Housekeeping: Attendee participation

Treatment Alternatives for Substance Use Disorders

ADDING EVEN MORE SUBSTANCE TO MANAGED CARE

OPIOIDS IN AMERICA. A complex crisis. A comprehensive response.

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Treating Opioid Addiction

4/5/2018 MEDICATION ASSISTED TREATMENT FOR OPIOID USE DISORDERS OBJECTIVES DEFINITION OF ADDICTION APRIL 11, 2018 RITU BHATNAGAR, M.D., M.P.H.

Buprenorphine Prescribing as a Patient- Centered Medical Home Enhancement

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

New Guidelines for Opioid Prescribing

Appendix F Federation of State Medical Boards

State Opioid Response (SOR) Grant

METHADONE TO BUPRENORPHINE TRANSFERS TRANSITIONING FROM METHADONE MAINTENANCE TO BUPRENORPHINE/NALOXONE

Opioid Use Disorder Treatment Initiation in Diverse Settings

Prepublication Requirements

Patient Agreement for the use of Opioid Medications

IDDT Fidelity Action Planning Guidelines

Mobilizing a Response to the Opioid Epidemic: County Snapshots. Kelly Pfeifer, MD May 10, 2018

SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

COMMUNITY-BASED SUBSTANCE USE DISORDER FEE SCHEDULE (eff July 1, 2018) Provider Type 32: Opioid Treatment Program

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

NP Application for Authority/Exemption to Prescribe Methadone for Opioid Dependence Part A (Initial application)

Division of Mental Health and Addiction Services

Transcription:

Vermont Hub and Spoke Model Treatment Need Questionnaire Friday, June 30, 2017 John Brooklyn, MD Assistant Professor of Family Medicine and Psychiatry University of Vermont Burlington, Vermont

Webinar Reminders 1.Everyone is muted. Press *7 to unmute and *6 to mute yourself. 2.Remember to chat in questions! 3.Webinar is being recorded and will be posted and sent out via email

Hub & Spoke Model: Integrated Health Systems for Addictions Treatment Corrections Family Services Spokes Residential Services Mental Health Services Spokes Hub Assessment, care coordination, methadone, complex addictions, consultation Spokes Inpatient Services Substance Use Outpatient Treatment Nurse Counseling Teams w/ prescribing MD Medical Homes Pain Management Clinics

Spokes: Overview & Practice Setting Spoke: The ongoing care system comprised of a prescribing physician & collaborating health & addictions professionals who monitor adherence to treatment, coordinate access to recovery supports, & provide counseling, contingency management, & case management services Spokes can be any of the following practice settings: Primary Care Providers Blueprint Advanced Practice Medical Homes Outpatient Substance Use Treatment Providers Federally Qualified Health Centers Independent Psychiatrists

Level of care Community providers often do not know if they can take care of of someone with opioid use disorder in the office Buprenorphine waiver training does not go into detail of complexity Many providers feel overwhelmed to start prescribing buprenorphine Not sure of the resources that may be needed Most of the time it was the medication rather than the setting that determined the care provided (bup in office, methadone in a clinic)

Determining Intensity of Care Treatment Needs Questionnaire OBOT is office based opioid treatment with bup and can be a Spoke OTP is opioid treatment program with methadone and bup and is a Hub Required use for VT Hub providers, encouraged use for Spoke providers to develop consistent triage screening process Does not consider ER-Naltrexone as an option in the algorithm Scoring Scores up to 26 with lower scores predicting good Spoke outcomes 0-5: Excellent candidate for officebased treatment 6-10: Good candidate for officebased treatment with on site behavioral health services 11-15: Candidate for office based treatment by board certified addiction physician in a tightly structured program with supervised dosing & on-site counseling or HUB 16-26: Hub program 6

Triage tool-treatment Need Questionnaire (TNQ) Author (JB) wrote down the challenges between Methadone program and Office Based Opioid Treatment patients Loosely based on Addiction Severity Index by McLellan et al. Areas of concern Legal Family Social Psychological Occupational Medical Drug and Alcohol use

TNQ 21 items Score of 26 max Higher scores may mean more services or expertise is needed Some items weighed more heavily than others based on research literature and professional experience Not yet validated as predictive by controlled trials

TNQ copyrighted Copyrighted under Creative Commons Attribution-Non Commercial- No Derivates 4.0 International License. If used must: Attribute it to authors (Brooklyn and Sigmon) No commercial use or distribution without permission No changes to be made We agree to give you rights to use this in your work and to share it amongst your organization but not to release it to anyone outside of your organization or group with whom you are working. The Creative Commons disclaimer on the bottom of the form must not be removed or altered.

TNQ scoring Low scores of 0-5 We thought any provider could deal with this person in an OBOT Spoke Score of 6-10 Any OBOT Spoke provider with on site behavioral health program and access to an addiction specialist as a mentor Score of 11-15 Needed Hub level or addiction specialist with resources at hand such as counseling, drug screening, and admin help Score of 16 or higher Hub level However, lower scores could be at a Hub and move to a Spoke over time if on bup (or methadone for pain)

TNQ Most valuable at initial contact and not designed to measure progress over time Gives the provider a snapshot that requires further questioning at intake Can be given to patient to answer on own and then handed to provider May be administered by admin staff but needs to be evaluated further by provider or trained personnel

Validity Many of the items have been shown to be predictive of stability in treatment These items were given scores of a 2 Intravenous drug use Cocaine use Benzodiazepine use Alcohol use Chronic pain Previous success in medication assisted treatment program

Validity Rest of the items added to look at issues that will impact decisions on treatment location and were given scores of 1 Employment and education Psychological issues Medical issues Family and social supports Legal issues, especially drug dealing Travel and access issues Motivation

Scores of 2 IV drug use associated with higher severity of disease and often predicts need for long term treatment with MAT. Addict Behav. 2015 Mar;42:189-93. doi: 10.1016/j.addbeh.2014.11.006. Epub 2014 Nov 18. Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers. Meyer AC 1, Miller ME 2, Sigmon SC 3.

Scores of 2 Cocaine use associated with poorer treatment outcome at intake J Addict Dis. 2006;25(1):43-50. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. Peles E 1, Kreek MJ, Kellogg S, Adelson M. Need to assess frequency and last use of cocaine. If it was in the distant past, it may still be an issue once the person enters treatment and can no longer use opioids. Can also be treated with higher doses of buprenorphine

Scores of 2 Alcohol and BZD use associated with less stable individuals Many providers do not know how to deal with these disorders Many opioid users are prescribed BZD to manage anxiety Many mix both and can be at risk for morbidity and mortality However, both Alcohol use disorder and anxiety can be managed in the office if enough resources are available Alcohol and opioids work on similar parts of the brain so people may resume use once on MAT

Chronic pain May indicate need for methadone Also implies need for more psychological support May be managed with buprenorphine but not as well Worsened by tobacco smoking which 99% of heroin users do so can imply the need for management of tobacco use in the office

Previous treatment May predict poor outcome and need for more services Also need to ask why they left treatment or what did not work and then try not to repeat the same mistakes Self reported so requires more data

Scores of 1 Transportation-may mean the person CAN T get to a clinic daily even though the TNQ score is high Phone-need to be able to reach them in spoke for appointments Family and friends show what social supports they have and risks for ongoing use Work-can you get to Hub due to work or is a more flexible appointment schedule best? Housing-can the person store the medication safely if in spoke? Motivation and meetings-implies good network and not coerced for treatment

Legal issues Many have them Will they return to jail and is MAT (Bup/mtd) available to them in jail? Dealing history implies higher risk of diversion and less compliance May also mean ongoing drug use exposure if still involved in those circles and thus needs Hub level Probation often is an incentive to be in treatment

Scoring Add it up and look at the score Use your gestalt about the person If you decide to treat in the office, what are your must dos? Low scores may not predict quantity of heroin used and level of distress Can always try to work with someone with a higher score and see if they get better Any day someone is not sticking a needle in their body is a good day as their risk of Overdose diminishes

Q & A

Contact Information John Brooklyn, MD jbrookly@uvm.edu THANK YOU!